Quality by DesignDevelopment, optimization and robustness by DesignMayank
Global initiatives
Global initiativesReferences1. ICH, Q8(R1) Pharmaceutical Development (Geneva, Switzerland, Nov. 10, 2005; Rev. 2008). 2. ICH, Q9 Quality Risk Management (Geneva, Switzerland, Nov. 9. 2005). 3. J. Agalloco et al., "FDA's Guidance for Industry: Process Validation: General Principles and Practices," presented at PDA, Jan. 14, 2009. 4. FDA, Draft Guidance for Industry—Process Validation: General Principles and Practices (Rockville, MD, Nov. 2008). 5. W. Charlton, T. Ingallinera, and D. Shive, "Validation of Clinical Manufacturing," and Validation Chapter, in Validation of Pharmaceutical Process, J. Agalloco and F. Carleton, eds. (Informa Healthcare, New York, 3rd ed., 2008), pp. 542–544.
Quality by design (QbD)What is QbD?Product and process performance characteristics are scientifically designed to meet specific objectives, not merely empirically derived from performance of test batchesFocus during developmentCritical Quality Attributes (CQA)eg.     USPDSPCell viability
Cell count
Titre
Product characteristics (egGlycocylation)
Impurity profile
Overall purity
Type of impurity (eg HCP, endotoxins, DNA,)
Yield Critical Process Parameter (CPP)Column bed height and packing efficiency
Media selectivity
Media particle size
Dynamic capacity
Buffer conditions (eg pH, conductivity)
Temperature
Flow rate
Sample load
Temperature
pH
Agitation
DO
Medium composition
Osmolarity
Feed type
Process type (eg Batch, fed batch or perfustion)Quality by design (QbD)Tools for successful implementation of QbDTeam:Engineers
Biologists
Analysts
Chemists
Industrial pharmacist
SatiationsAnalytical equipmentsOnline/Atline
NIR detectors
Methanol sensors
CO2/O2 probes

Quality By Design